Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus.
about
The role of adenosinergic pathway in human autoimmune diseasesPathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus ErythematosusFcγRIIIa-Syk Co-signal Modulates CD4+ T-cell Response and Up-regulates Toll-like Receptor (TLR) ExpressionHerpesviruses dUTPases: A New Family of Pathogen-Associated Molecular Pattern (PAMP) Proteins with Implications for Human DiseaseThe regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus.IL-17A Monoclonal Antibody Partly Reverses the Glucocorticoids Insensitivity in Mice Exposed to Ozonec.Circulating concentrations of interleukin (IL)-17 in patients with multiple sclerosis: Evaluation of the effects of gender, treatment, disease patterns and IL-23 receptor gene polymorphismsPrevention of immune nephritis by the small molecular weight immunomodulator iguratimod in MRL/lpr mice.Increased Th17 cells in flow cytometer-sorted CD45RO-positive memory CD4 T cells from patients with systemic lupus erythematosus.Prospective study in a porcine model of sarcoptes scabiei indicates the association of Th2 and Th17 pathways with the clinical severity of scabiesRegulation of autoimmune germinal center reactions in lupus-prone BXD2 mice by follicular helper T cellsBone Loss Triggered by the Cytokine Network in Inflammatory Autoimmune Diseases.The c.503T>C Polymorphism in the Human KLRB1 Gene Alters Ligand Binding and Inhibitory Potential of CD161 Molecules.Complement C4 induces regulatory T cells differentiation through dendritic cell in systemic lupus erythematosus.Memory Stem T Cells in Autoimmune Disease: High Frequency of Circulating CD8+ Memory Stem Cells in Acquired Aplastic Anemia.Establishing a tree shrew model of systemic lupus erythematosus and cell transplantation treatment.Serum Cytokines Th1, Th2, and Th17 Expression Profiling in Active Lupus Nephritis-IV: From a Southern Chinese Han PopulationIL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: Evidence for a dual role.Basophil Activation-Dependent Autoantibody and Interleukin-17 Production Exacerbate Systemic Lupus ErythematosusInteractions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases.Association of variants in CCR6 with susceptibility to lupus nephritis in ChinesePlasmablasts with a mucosal phenotype contribute to plasmacytosis in SLE.miRNA-451a Targets IFN Regulatory Factor 8 for the Progression of Systemic Lupus Erythematosus.Th17 Responses to Collagen Type V, kα1-Tubulin, and Vimentin Are Present Early in Human Development and Persist Throughout Life.Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus.Signal transducer and activator of transcription (STAT) 3 inhibition delays the onset of lupus nephritis in MRL/lpr mice.Dysregulated Responsiveness of Circulating Dendritic Cells to Toll-Like Receptors in ANCA-Associated Vasculitis.Antibiotics ameliorate lupus-like symptoms in mice.Anti‑IL‑39 (IL‑23p19/Ebi3) polyclonal antibodies ameliorate autoimmune symptoms in lupus‑like mice.Abnormal CD161+ immune cells and retinoic acid receptor-related orphan receptor γt-mediate enhanced IL-17F expression in the setting of genetic hypertension.The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.When worlds collide: Th17 and Treg cells in cancer and autoimmunity.Human umbilical cord derived mesenchymal stem cells promote interleukin-17 production from human peripheral blood mononuclear cells of healthy donors and systemic lupus erythematosus patients.
P2860
Q28069199-8A3772D9-62F9-4262-B1AF-FFEB9F87BB36Q28088753-D67D87BD-3C36-4F6F-B2C3-8403A3B9DADEQ30698666-F713666B-B20D-4969-97C6-621B0E1AEFEAQ31152067-510A84F1-7D80-4827-B552-66280A4101DAQ33652093-5D657789-49AD-4E8C-8C62-CE2968FDAA30Q33676504-BCF96CCC-C21C-438C-A76A-9A7014C17162Q33896806-D376F5C6-7C38-4735-96FC-943D7BCF1DB6Q34278189-55DD6616-D35A-48EA-834A-E4771885B7CCQ34739451-B8F53726-0762-4C65-9E62-926468ADAC39Q35136982-2104928A-C121-4456-94AD-0CA9FFDCAC55Q35175080-3062A374-C153-49AF-AF88-0DD6C54BD47AQ35614331-B3ED776B-A226-4AF3-926C-98DC822E80C4Q35756252-65C9EDE7-64FF-4A4F-B5E4-49B50EEB3D5EQ36402107-7AFC7215-AD32-4E7B-87E7-E409BA797E59Q36553599-9772096D-7AE3-44EC-9841-038FAB20FE0FQ37199240-3565D9D7-E30C-4738-A368-D1273B2BA6F7Q37322751-222C14F3-641A-4E68-A649-FA288BCD0BB4Q37679294-6FCA8B09-77C8-49AE-949E-DAC5BCFDB696Q37721290-FE0045DC-CB75-432A-A025-6C743A76793EQ37737549-18BBF439-5B15-447F-A864-503C33D4EE4EQ37743913-227A227C-8911-4A15-BB18-5D508FE86A1DQ38722252-F8A5F523-01FA-4ECF-8A76-8430F0BA498DQ39000849-5C63BB4E-36AB-4FBC-91B7-D3871D3DD241Q39228029-5B4A6325-D1A4-4C58-9637-A9E79E89401CQ40660212-C8C8A086-B0A4-44E4-A93B-D0EC6BF99ABFQ41831402-9F7718F5-0F44-4506-931F-2F3D027C0B2BQ42323025-318A44F4-8C34-4623-8AFC-C95AC29A614CQ42653229-05C8954A-268B-4633-9119-B7D6D565B3D2Q47401182-D1B861BB-6360-4D8E-A069-FCF3204030FDQ47992065-128F4167-0936-4E72-BE8A-D9048E209976Q48620175-D4308D8E-5944-4336-9128-F2B90D086CEFQ52689973-A21A153D-5B5A-41EE-A812-04411A02C760Q53298325-6C2239F0-0790-4540-B8CD-FCF2EA15CB56
P2860
Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus.
@en
type
label
Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus.
@en
prefLabel
Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus.
@en
P1433
P1476
Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus.
@en
P2093
Dominique L Baeten
Jérôme C Martin
P356
10.1016/J.CLIM.2014.05.004
P50
P577
2014-05-23T00:00:00Z